Key result
Chronic kidney disease was independently associated with an increased risk of cardiovascular autonomic neuropathy in diabetic patients.
Why the study?
The study was conducted to determine the relationship between chronic kidney disease and cardiovascular autonomic neuropathy.
Is chronic kidney disease associated with cardiovascular autonomic neuropathy in subjects with and without diabetes?
Cross-Sectional (n=280)
Is chronic kidney disease associated with cardiovascular autonomic neuropathy in subjects with and without diabetes?
Answers are grounded in this paper and cite their sources.
Chronic kidney disease, assessed by eGFR and albuminuria, is significantly associated with an increased risk of cardiovascular autonomic neuropathy, particularly in patients with diabetes.
Objective The purpose of this study was to determine the relationship between chronic kidney disease (CKD) and cardiovascular autonomic neuropathy (CAN). Research design and methods From October 2008 to May 2011, we enrolled 218 patients with diabetes and 62 nondiabetic subjects. Heart rate variability was represented as the maximal heart rate minus the minimal heart rate (HR max-min ) during a one-minute deep breathing test. Normal, impaired cardiovascular autonomic function and CAN were defined as s HR max-min > 15 beats/min, HR max-min of 10–15 beats/min and HR max-min < 10 beats/min, respectively. CKD was diagnosed if the estimated glomerular filtration rate (eGFR) was <60/min/1.73 m 2 or albuminuria. Results In our sample, 19.4% of nondiabetic subjects and 49.5% of diabetic subjects had CKD. The prevalence of CAN was higher among patients with diabetes than among nondiabetic subjects (26.4 vs. 4.9%). A significant association was observed between eGFR and HR max-min . CAN was independently associated with CKD with an adjusted odds ratio of 2.77 (95% CI, 1.15–6.68) in diabetic patients. A positive linear trend was observed for the odds of CAN with increasing CKD severity in diabetes. The areas under the curve (AUCs) for the predictive ability of eGFR for the risk of impaired cardiovascular autonomic function for nondiabetic group and CAN for the diabetic group were 0.734 and 0.703, respectively. Adding age, sex, body mass index, and albuminuria to the prediction model increased the AUCs to 0.852 and 0.791, respectively. Conclusion CKD is associated with the risk of CAN in both nondiabetic and diabetic subjects. eGFR and albuminuria improve the prediction of CAN.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2020) conducted a cross-sectional in Diabetes and Chronic Kidney Disease (n=280). Chronic kidney disease vs. Absence of chronic kidney disease was evaluated on Cardiovascular autonomic neuropathy (CAN) (OR 2.77, 95% CI 1.15-6.68). Chronic kidney disease was independently associated with an increased risk of cardiovascular autonomic neuropathy in diabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: